View source for ICD in the context of abnormal troponin

__NOTOC__
{{Implantable Cardioverter Defibrillator ACC/AHA/HRS Guidelines}}
{{CMG}}; {{AE}}{{DN}}

==ICD Implantation In The Context of an Abnormal Troponin That is Not Due To a Myocardial Infarction<ref name="pmid24820349">{{cite journal |vauthors=Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L |title=HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials |journal=J. Am. Coll. Cardiol. |volume=64 |issue=11 |pages=1143–77 |year=2014 |pmid=24820349 |doi=10.1016/j.jacc.2014.04.008 |url=}}</ref>==

{|class="wikitable"
|-
| colspan="1" style="text-align:center; background:LightGreen"|Recommended
|-
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' In patients with abnormal cardiac biomarkers that are not thought to be due to an MI and who otherwise would be candidates for implantation on the basis of primary prevention or secondary prevention criteria, implantation of an ICD is recommended.<nowiki>"</nowiki>
|-
|}